Table 4.
ARM A VERSUS B VISCERAL METASTASES | ARM A VERSUS B BONE METASTASES | |||
---|---|---|---|---|
RR | P-VALUE | RR | P-VALUE | |
Age | ||||
18–<40 | 0.7 | 0.04 | 0.9 | 0.09 |
40–<51 | 0.8 | 0.05 | 1.0 | 0.1 |
51–<65 | 0.9 | 0.07 | 1.0 | 0.1 |
65–70 | 1.0 | 0.1 | 1.1 | 0.1 |
Performance status:(ECOG) | ||||
0 | 1.0 | 0.1 | 1.0 | 0.09 |
1 | 1.0 | 0.1 | 0.9 | 0.1 |
2 | 0.8 | 0.07 | 0.9 | 0.09 |
Pathological classification | ||||
Ductal | 0.8 | 0.04 | 1.1 | 0.09 |
Lobular | 0.9 | 0.09 | 0.9 | 0.09 |
Pathological grade | ||||
1 | 0 | 0 | 0 | 0 |
2 | 0.8 | 0.06 | 1.0 | 0.1 |
3 | 0.6 | 0.04 | 1.1 | 0.09 |
Initial stage (pathological) | ||||
I–II | 1.0 | 0.1 | 1.1 | 0.1 |
III | 0.8 | 0.05 | 0.9 | 0.9 |
Number of positive lymph node | ||||
0 | 1.0 | 0.1 | 1.2 | 0.1 |
1–3 | 1.0 | 0.07 | 1.1 | 0.1 |
4–9 | 0.8 | 0.05 | 1.0 | 0.09 |
>9 | 0.6 | 0.01 | 0.07 | 0.04 |
Receptor status: Her 2 neu | ||||
Positive | 0.6 | 0.03 | 1.1 | 0.07 |
Negative | 0.7 | 0.05 | 1.2 | 0.09 |
Invasion | ||||
Lymphatic | 0.7 | 0.05 | 0.8 | 0.09 |
Vascular/Perineural | 0.8 | 0.09 | 1.0 | 0.1 |